Insiders · Profile

Gloria Melanie

Chief Operating Officer at Immunovant. Filing since 20 Nov 2025. CIK 0001973838

Company
Date
Role
Action
Shares
Amount
Of holding
7 Oct 2026
Chief Operating Officer
Sold at will
2,241
$71.85K
1.0%
20 Aug 2026
Chief Operating Officer
Sold at will
3,056
$134.95K
1.4%
8 Jul 2026
Chief Operating Officer
Sold at will
2,036
$80.53K
0.9%
26 Jun 2026
Chief Operating Officer
Sold at will
17,714
$678.60K
7.3%
20 May 2026
Chief Operating Officer
Sold at will
3,115
$101.07K
1.3%
8 Apr 2026
Chief Operating Officer
Sold at will
8,722
$216.57K
3.4%
25 Feb 2026
Chief Operating Officer
Sold at will
3,238
$90.18K
1.9%
20 Nov 2025
Chief Operating Officer
Sold at will
12,626
$298.24K
6.8%
8 decisions on file.